Evaluation of the effects of chemotherapy on brain glucose metabolism in children with Hodgkin's lymphoma.
Fiche publication
Date publication
mai 2019
Journal
Annals of nuclear medicine
Auteurs
Membres identifiés du Cancéropôle Est :
Pr NAMER Izzie-Jacques, Pr FORNECKER Luc-Matthieu, Dr NOBLET Vincent
Tous les auteurs :
Tauty A, Noblet V, Paillard C, Fornecker LM, Namer IJ, Bund C
Lien Pubmed
Résumé
Chemobrain is a recently proposed pathological entity. F-FDG PET/CT can show objective abnormalities to explain brain disorders caused by chemotherapy, although no study has investigated these phenomena in children to date. The main objective of the present study was to examine quantitatively the effects of chemotherapy on brain metabolism in a homogeneous population of children treated for Hodgkin's lymphoma using 18F-FDG PET/CT.
Mots clés
Chemobrain, Chemofog, FDG PET, Hodgkin’s lymphoma
Référence
Ann Nucl Med. 2019 May 13;: